Morningstar, Inc. (MORN) vs. Zentalis Pharmaceuticals, Inc. (ZNTL) Stock Comparison & Valuation

Quick read

Fair value engine

Each company valued on the other's multiple, then compared with the market price.

MORN · current priceP/S 3.21x

$209.44Latest market snapshot

Implied fair value · at ZNTL's multiple

$277.8832.7% above market

65.19 MORN revenue / share×4.26x ZNTL P/S=$277.88

Market $209.44Implied $277.88

ZNTL · current priceP/S 4.26x

$4.01Latest market snapshot

Implied fair value · at MORN's multiple

$3.0224.6% below market

0.94 ZNTL revenue / share×3.21x MORN P/S=$3.02

Market $4.01Implied $3.02

Engine logicMORNvalued onZNTL’smultiple